Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Blackstone and TPG weigh private credit participation in $12.25bn Hologic buyout financing
Blackstone and TPG weigh private credit participation in $12.25bn Hologic buyout financing Wall Street banks are exploring the inclusion of private credit lenders in the $12.25bn debt package backing Blackstone and TPG’s $18.3bn acquisition of Hologic, in a move that...
EQT deepens Asia tech push with $930m bet on South Korea’s Douzone Bizon
EQT deepens Asia tech push with $930m bet on South Korea’s Douzone Bizon EQT has agreed to acquire a 37.6% stake in South Korean enterprise software company Douzone Bizon for approximately $930m, marking one of the private equity firm’s largest Asian investments this...
Aquarian Capital to take Brighthouse private in $4.1bn deal backed by Mubadala and RedBird
Aquarian Capital to take Brighthouse private in $4.1bn deal backed by Mubadala and RedBird Aquarian Capital has agreed to acquire US insurer Brighthouse Financial in a $4.1bn all-cash transaction, marking one of the year’s largest private equity-led takeovers in the...